Els read Chemical Engineering and obtained an MBA at VUB University, Belgium. She has over 15 years of experience in clinical research and development, financial analysis, venture capital investments and financial management. She is an experienced dealmaker, with a knowledge base of venture capital and pre-IPO universe. Els has served on the board of directors of several companies and funds, including amongst others Capricorn Venture Fund II, Algonomics, 4AZA, Nexstim Oy, Sequana Medical and Sphere Medical. Currently she is on the board of Biogazelle. She was a key member of the team manageing the KBC ARKIV fund, an initiative aimed at SME’s and Quest for Growth, a Euronext listed closed-end fund. In her most recent position at QBIC Venture Partners, Belgium, Els has been actively involved in the creation and financing of spin-offs of the universities of Antwerp, Brussels and Ghent.